ClinicalTrials.gg
Drug

Ozanimod clinical trials

Also written RPC1063, Zeposia® and BMS-986374.

studies test it
37
open now
4
in phase 3
16
first study started
2012

How each study uses ozanimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the ozanimod studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Mar 2020 · ZEPOSIA · NDA 209899 (FDA, Drugs@FDA)
European Union
20 May 2020 · Zeposia · EMEA/H/C/004835 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ozanimod
32
Ozanimod Oral Capsule
2

Brand

Zeposia®
7

Development codes

RPC1063
14
BMS-986374
4

Studies by the year they started

37 studies that test it; most in 2018 (7)

Studies that test ozanimod, by start year
YearStudies
20122
20131
20141
20154
20162
20187
20192
20205
20212
20223
20232
20244
20252

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
7
Phase 3
16
Phase 4
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 31 · Other 6

Celgene (24) · Bristol-Myers Squibb (7) · ChenXiaoChun (1) · University of Colorado, Denver (1) · I.R.C.C.S. Fondazione Santa Lucia (1) · Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec (1) · Geert D'Haens (1) · The University of Texas at Dallas (1)

Often tested with

Tested in the same studies.

Phenelzine (1) · Tyramine (1) · Pseudoephedrine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test ozanimod.

Studies

Open first, then newest update. How each study uses ozanimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 37

See all 37 studies that test ozanimod →

Codes

What other systems call ozanimod · ClinicalTrials.gg INT000460

  • MeSH (NLM) C000607776ozanimodConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) Z80293URPVOZANIMODConfirmed FDA, NLM, Wikidata
  • RxNorm 2288236Confirmed FDA, Wikidata
  • Wikidata Q21098986ozanimodConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C170279OzanimodOne source FDA
  • DrugBank DB12612One source Wikidata

Also registered as ozanimod hydrochloride (UNII 3UPR33JAAM · RxNorm 2288235).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.